Research Article
Analysis of the Clinical Value of Delphian Lymph Node Metastasis in Papillary Thyroid Carcinoma
Table 3
DLN clinical and pathological features in univariate analysis.
| | Characteristics | DLN-positive n (%) | DLN-negative n (%) | value |
| | Sex | | | 0.016 | | Male | 29 (27.4) | 71 (17.1) | | | Female | 77 (72.6) | 345 (82.9) | | | Age | | | 0.053 | | ≥55 years | 97 (91.5) | 350 (84.1) | | | <55 years | 9 (8.5) | 66 (15.9) | | | Tumor size | | | <0.001 | | ≤1 cm | 35 (33.0) | 322 (77.4) | | | >1 cm | 71 (67.0) | 94 (22.6) | | | Multifocality | | | 0.363 | | Single | 85 (80.2) | 349 (83.9) | | | Multiple | 21 (19.8) | 67 (16.1) | | | Bilaterality | | | 0.129 | | Bilateral | 74 (69.8) | 320 (76.9) | | | Unilateral | 32 (30.2) | 96 (23.1) | | | Tumor location | | | 0.003 | | Upper | 35 (33.3) | 98 (23.6) | | | Middle | 41 (38.7) | 162 (38.9) | | | Low | 21 (19.8) | 142 (34.1) | | | Isthmus | 9 (8.5) | 14 (3.4) | | | ETE | | | <0.001 | | Yes | 23 (21.7) | 31 (7.5) | | | No | 83 (78.30) | 385 (92.5) | | | Hashimoto’s thyroiditis | | | 0.060 | | Yes | 18 (17.0) | 107 (25.7) | | | No | 88 (83.0) | 309 (74.3) | | | Close to capsule | | | 0.026 | | Yes | 6 (5.7) | 6(1.4) | | | No | 100 (94.3) | 410 (98.6) | | | CLNM | | | <0.001 | | Yes | 89 (84.0) | 124 (29.8) | | | No | 17 (16.0) | 292 (70.2) | | | LLNM | | | <0.001 | | Yes | 32 (30.2) | 9 (2.2) | | | No | 74 (69.8) | 407 (97.8) | | | Mean largest size of an LNM, cm | | | <0.001 | | Mean ± SD | 2.71 ± 1.07 | 2.12 ± 0.75 | | | Cancerous nodules | | | 1.000 | | Yes | 1 (0.9) | 4(1.0) | | | No | 105 (99.1) | 412 (99.0) | | | Locoregional recurrence | | | 0.028 | | Yes | 3 (2.8) | 1 (0.2) | | | No | 103 (97.2) | 415 (99.8) | |
|
|
DLN, Delphian lymph node; SD, standard deviation; LLNM, lateral lymph node metastasis; CLNM, central lymph node metastasis; ETE, extrathyroidal extension.
|
